94766-3

SARS-CoV-2 (COVID-19) N gene [Presence] in Serum or Plasma by NAA with probe detection

Active

Term Description

Qualitative detection of nucleic acids within the nucleoprotein (N) gene of SARS coronavirus 2 (SARS-CoV-2) in serum or plasma by nucleic acid amplification with probe-based detection.
Source: Regenstrief LOINC

Part Description

LP417599-0 SARS coronavirus 2 N gene
The Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), first known as 2019 Novel Coronavirus (2019-nCoV), was first identified as the cause of a respiratory illness outbreak, later defined as Coronavirus Disease 2019 (COVID-19), in Wuhan, China. The full genome of the SARS-CoV-2 that causes COVID-19 was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Real time Reverse Transcription-Polymerase Chain Reaction (rRT-PCR) tests targeting regions within genes, including RdRp, S, N, M, and E genes, specific to SARS-CoV-2 have been developed by the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO) and others for the diagnosis of COVID-19. Some assays only detect SARS-CoV-2 and other assays detect other strains (e.g. SARS-CoV) that are genetically similar.[CDC: coronavirus/2019-ncov][https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance] Source: Regenstrief LOINC

Reference Information

Type	Source	Reference
Webcontent	Lab Tests Online^®Copyright Copyright © 2021 Lab Tests Online. All rights reserved.	Coronavirus (COVID-19) Testing

Fully-Specified Name

Component: SARS coronavirus 2 N gene
Property: PrThr
Time: Pt
System: Ser/Plas
Scale: Ord
Method: Probe.amp.tar

Additional Names

Short Name: SARS-CoV-2 N gene SerPl Ql NAA+probe
Display Name: SARS-CoV-2 (COVID-19) N gene NAA+probe Ql
Consumer Name Alpha Get Info: SARS-CoV-2 (COVID-19) N gene, Blood

Ask at Order Entry

81959-9 Public health laboratory ask at order entry panel

This panel contains a convenience grouping of terms for questions commonly asked when an order is placed in a public health laboratory.

LOINC	Name	R/O/C	Example UCUM Units
81959-9	Public health laboratory ask at order entry panel
Indent81744-5	Submitter's laboratory test method [Type] in Specimen
Indent81658-7	Suspected organism [Identifier] in Specimen
Indent86952-9	Preliminary testing done Specimen
Indent86953-7	Preliminary testing result Specimen
Indent86955-2	Preliminary testing affected submission for further testing Specimen
Indent95417-2	Whether this is the patient's first test for condition of interest
Indent95418-0	Whether patient is employed in a healthcare setting
Indent95419-8	Whether the patient has symptoms related to condition of interest
Indent11368-8	Illness or injury onset date and time	C
Indent77974-4	Whether the patient was hospitalized for condition of interest
Indent95420-6	Whether the patient was admitted to intensive care unit (ICU) for condition of interest
Indent95421-4	Whether patient resides in a congregate care setting
Indent82810-3	Pregnancy status	C
Indent30525-0	Age		a

Example Answer List: LL956-4

Source: Regenstrief LOINC

Answer	Code	Score	Answer ID
Detected			LA11882-0
Not detected			LA11883-8
EquivocalCopyright http://snomed.info/sct ID:42425007 Equivocal (qualifier value)			LA11885-3
InconclusiveCopyright http://snomed.info/sct ID:419984006 Inconclusive (qualifier value)			LA9663-1

Basic Attributes

Class: MICRO
Type: Laboratory
First Released: Version 2.68
Last Updated: Version 2.69
Order vs. Observation: Both

Member of these Groups Get Info

LOINC Group	Group Name
LG51017-8	SARSCoV2 detection
LG51019-4	SARSCoV2 molecular detection

Language Variants Get Info

Tag	Language	Translation
de-DE	German (Germany)	SARS-Coronavirus 2 N-Gen:Nachweis oder Schwellenwert:Zeitpunkt:Serum oder Plasma:Ordinal:Zielfragmentamplifikation mit Sondendetektion
es-ES	Spanish (Spain)	Gen N de SARS-CoV-2 (COVID-19):PrThr:Punto temporal:Suero o Plasma:Ord:Sonda con amplificación dirigida
es-MX	Spanish (Mexico)	Gen del coronavirus 2 N del SARS:Presencia o umbral:Punto temporal:Suero o Plasma:Ordinal:Amplificación de ácidos nucleicos con detección de sonda
fr-CA	French (Canada)	Gène N du coronavirus 2 du SRAS:Présence-Seuil:Temps ponctuel:Sérum/Plasma:Ordinal:Sonde avec amplification de la cible
fr-FR	French (France)	Coronavirus SARS-CoV-2 gène N:Présence/Seuil:Ponctuel:Sérum/Plasma:Qualitatif:PCR amplification de cible
it-IT	Italian (Italy)	SARS coronavirus 2, gene N:PrThr:Pt:Siero/Plasma:Ord:Sonda.amp.tar Synonyms: Coronavirus della SARS Gene N di SARS-CoV-2 (COVID-19) Microbiologia Plasma Presenza o Soglia Punto nel tempo (episodio) SARS-CoV-2 (COVID-19) Siero Siero o Plasma Sonda con amplificazione Sonda con amplificazione del target Sonda di DNA
nl-NL	Dutch (Netherlands)	SARS-CoV-2 N-gen:aanwezigheid:moment:serum of plasma:ordinaal:probe-detectie Synonyms: evere acute respiratory syndrome coronavirus 2; 2019-nCoV; 2019 novel coronavirus; COVID-19 probe.amp.tar SARS-virus severe acute respiratory syndrome coronavirus 2; 2019-nCoV; 2019 novel coronavirus; COVID-19
zh-CN	Chinese (China)	SARS 冠状病毒 2 N 基因:存在情况或阈值:时间点:血清/血浆:序数型:探针法.基因扩增.靶向 Synonyms: 2019 新型冠状病毒;2019 年新型冠状病毒;2019-nCoV;SARS-CoV-2;新型冠状病毒肺炎;新冠肺炎;Coronavirus disease 2019;COVID-19;冠状病毒疾病2019;严重急性呼吸综合征;severe acute respiratory syndrome;SARS;传染性非典型肺炎;infectious atypical pneumonia;非典 Ⅱ II N 型 SARS;SARS 病毒;SARS-CoV;严重急性呼吸综合征;严重急性呼吸综合征病毒;萨斯病毒;非典;非典型肺炎;非典型肺炎病毒;非典病毒依次型;分类顺序型;定性的;序数型（或称等级型）;性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型借助扩增的探针方法;借助扩增的探针法;探针法.扩增借助靶向扩增的探针方法;借助靶向扩增的探针法;探针法.扩增.靶向存在情况;存在;存在与否;是否存在;阈值;界值;界限;阀值;临界值;存在情况（存在、存在与否、是否存在）或阈值（界值、界限、阀值、临界值）微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体）扩增型扩增性时刻;随机;随意;瞬间经过扩增的脱氧核糖核酸探针血清或血浆遗传基因;遗传因子;吉恩;生物基因

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

CodeSystem lookup: https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=94766-3

Third Party Copyright

This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.

This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.

Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.

LOINC Copyright

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.